ABSTRACT
OBJECTIVES/HYPOTHESIS: Ear fullness and pressure is a common complaint seen in otolaryngology clinics and frequently is attributed to eustachian tube dysfunction (ETD). In addition to traditional tympanometry and physical examination, the seven-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) has recently been used to aid in the diagnosis of ETD and to assess its severity. Temporomandibular joint disorder (TMJD) is a common condition that causes similar symptoms to ETD and has been recognized as a potential confounding condition in patients presenting with ETD symptoms. We sought to determine the cross-sectional prevalence of ETD symptoms in patients with TMJD using the ETDQ-7. STUDY DESIGN: Prospective cross-sectional analysis. METHODS: An analysis was performed of ETDQ-7 scores in patients diagnosed with TMJD. RESULTS: A total of 21 patients with confirmed TMJD completed the ETDQ-7 at routine consult or follow-up for their TMJD. The mean ± standard deviation ETDQ-7 score for the cohort was 24.5 ± 12.5. Two-thirds of patients had an ETDQ-7 score of >14.5, which has been used in the literature to denote clinically significant ETD. No single question was scored significantly higher than the others. CONCLUSIONS: Symptoms of ETD are highly prevalent among patients with TMJD determined by patient-reported outcome measures. It is not clear if these symptoms reflect true derangement of eustachian tube function in these patients or whether there is only clinical similarity between ETD and TMJD. However, future research efforts may resolve this dilemma. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:E233-E236, 2020.
Subject(s)
Ear Diseases/etiology , Ear Diseases/physiopathology , Eustachian Tube/physiopathology , Temporomandibular Joint Disorders/complications , Temporomandibular Joint Disorders/physiopathology , Acoustic Impedance Tests , Cross-Sectional Studies , Female , Humans , Male , Prevalence , Prospective Studies , Surveys and QuestionnairesSubject(s)
Carotid Artery, Internal, Dissection/complications , Toothache/etiology , Aged , Carotid Artery, Internal, Dissection/diagnosis , Carotid Artery, Internal, Dissection/diagnostic imaging , Facial Pain/etiology , Female , Humans , Magnetic Resonance Angiography , Male , Maxilla , Middle AgedABSTRACT
OBJECTIVE: This study was designed to assess whether gastrointestinal administration of iodinated contrast media results in peripheral blood eosinophilia. MATERIALS AND METHODS: We studied 110 patients in a retrospective review. Diatrizoate meglumine and diatrizoate sodium for abdominal CT were administered to 98 of these patients; 22 of the 98 had also been given the same contrast medium administered by enema. The remaining 12 patients were given diatrizoate sodium for gastrointestinal fluoroscopy. A control group of 65 patients underwent single-contrast barium upper gastrointestinal or enema examinations. WBC and eosinophil counts were determined approximately 24 hr before the examination and every 24 hr thereafter, through the ninth day. RESULTS: Eosinophilia was detected in 17 (15.5%) of 110 patients after gastrointestinal administration of iodinated contrast media. The prevalence of eosinophilia after administration of iodinated contrast media was statistically significantly different compared with that in the control group, in which none of the 65 patients had eosinophilia (p < 0.001). Eosinophilia was detected 48 hr after application of iodinated contrast agents and lasted through the sixth day, with a peak on the fifth day. The prevalence of eosinophilia was independent of route of application, dose, or type of iodinated contrast medium. Eosinophilia in all cases was clinically asymptomatic. CONCLUSION: Eosinophilia that is caused by gastrointestinal administration of iodinated contrast media is a transient, clinically silent phenomenon. It may lead to unnecessary workup for known conditions associated with eosinophilia.
Subject(s)
Contrast Media/adverse effects , Diatrizoate Meglumine/adverse effects , Diatrizoate/adverse effects , Eosinophilia/chemically induced , Administration, Oral , Administration, Rectal , Adolescent , Adult , Aged , Aged, 80 and over , Blood , Contrast Media/administration & dosage , Diatrizoate/administration & dosage , Diatrizoate Meglumine/administration & dosage , Female , Humans , Male , Middle Aged , Retrospective StudiesABSTRACT
It has been estimated that 30% to 80% of the population has at least one tension-type headache each year. Tension-type headaches can be located in any region of the head, which can confuse a differential diagnosis with temporomandibular joint disorders and cervical dysfunction. The roles of temporomandibular joint disorders and cervical dysfunction in tension-type headache are evaluated. Definitions, pathophysiology, and treatment considerations for each are discussed.
